Stimuli-sensitive polymer prodrug nanocarriers by reversible-deactivation radical polymerization

IF 39 1区 化学 Q1 CHEMISTRY, MULTIDISCIPLINARY
Léa Guerassimoff, Marianne Ferrere, Amaury Bossion and Julien Nicolas
{"title":"Stimuli-sensitive polymer prodrug nanocarriers by reversible-deactivation radical polymerization","authors":"Léa Guerassimoff, Marianne Ferrere, Amaury Bossion and Julien Nicolas","doi":"10.1039/D2CS01060G","DOIUrl":null,"url":null,"abstract":"<p >Polymer prodrugs are based on the covalent linkage of therapeutic molecules to a polymer structure which avoids the problems and limitations commonly encountered with traditional drug-loaded nanocarriers in which drugs are just physically entrapped (<em>e.g.</em>, burst release, poor drug loadings). In the past few years, reversible-deactivation radical polymerization (RDRP) techniques have been extensively used to design tailor-made polymer prodrug nanocarriers. This synthesis strategy has received a lot of attention due to the possibility of fine tuning their structural parameters (<em>e.g.</em>, polymer nature and macromolecular characteristics, linker nature, physico-chemical properties, functionalization, <em>etc.</em>), to achieve optimized drug delivery and therapeutic efficacy. In particular, adjusting the nature of the drug–polymer linker has enabled the easy synthesis of stimuli-responsive polymer prodrugs for efficient spatiotemporal drug release. In this context, this review article will give an overview of the different stimuli-sensitive polymer prodrug structures designed by RDRP techniques, with a strong focus on the synthesis strategies, the macromolecular architectures and in particular the drug–polymer linker, which governs the drug release kinetics and eventually the therapeutic effect. Their biological evaluations will also be discussed.</p>","PeriodicalId":68,"journal":{"name":"Chemical Society Reviews","volume":" 12","pages":" 6511-6567"},"PeriodicalIF":39.0000,"publicationDate":"2024-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.rsc.org/en/content/articlepdf/2024/cs/d2cs01060g?page=search","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemical Society Reviews","FirstCategoryId":"92","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2024/cs/d2cs01060g","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Polymer prodrugs are based on the covalent linkage of therapeutic molecules to a polymer structure which avoids the problems and limitations commonly encountered with traditional drug-loaded nanocarriers in which drugs are just physically entrapped (e.g., burst release, poor drug loadings). In the past few years, reversible-deactivation radical polymerization (RDRP) techniques have been extensively used to design tailor-made polymer prodrug nanocarriers. This synthesis strategy has received a lot of attention due to the possibility of fine tuning their structural parameters (e.g., polymer nature and macromolecular characteristics, linker nature, physico-chemical properties, functionalization, etc.), to achieve optimized drug delivery and therapeutic efficacy. In particular, adjusting the nature of the drug–polymer linker has enabled the easy synthesis of stimuli-responsive polymer prodrugs for efficient spatiotemporal drug release. In this context, this review article will give an overview of the different stimuli-sensitive polymer prodrug structures designed by RDRP techniques, with a strong focus on the synthesis strategies, the macromolecular architectures and in particular the drug–polymer linker, which governs the drug release kinetics and eventually the therapeutic effect. Their biological evaluations will also be discussed.

Abstract Image

Abstract Image

通过可逆-失活自由基聚合实现对刺激敏感的聚合物原药纳米载体。
聚合物原药是基于治疗分子与聚合物结构的共价连接,从而避免了传统药物纳米载体通常遇到的问题和局限性,即药物只是被物理夹带在纳米载体中(如猝发释放、药物负载量低)。在过去几年中,可逆失活自由基聚合(RDRP)技术被广泛用于设计定制的聚合物原药纳米载体。这种合成策略之所以受到广泛关注,是因为可以通过微调其结构参数(如聚合物性质和大分子特性、连接物性质、物理化学性质、官能化等)来优化药物输送和疗效。特别是,通过调整药物-聚合物连接体的性质,可以轻松合成刺激响应型聚合物原药,实现高效的时空药物释放。在此背景下,这篇综述文章将概述利用 RDRP 技术设计的各种刺激敏感聚合物原药结构,重点关注合成策略、大分子结构,尤其是药物-聚合物连接体,因为它制约着药物释放动力学,并最终影响治疗效果。此外,还将讨论其生物学评价。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Chemical Society Reviews
Chemical Society Reviews 化学-化学综合
CiteScore
80.80
自引率
1.10%
发文量
345
审稿时长
6.0 months
期刊介绍: Chemical Society Reviews is published by: Royal Society of Chemistry. Focus: Review articles on topics of current interest in chemistry; Predecessors: Quarterly Reviews, Chemical Society (1947–1971); Current title: Since 1971; Impact factor: 60.615 (2021); Themed issues: Occasional themed issues on new and emerging areas of research in the chemical sciences
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信